search for
or search by
Results 1 - 20 of 390
West Highlights Rigid Needle Shields for Prefilled Syringes
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, provided more information on its product offering, the Rigid Needle Shield (RNS), at the Parenteral Drug Association (PDA) Europe Annual Meeting.
Q BioMed Finalizes License Agreement for Novel Liver Cancer Treatment
Q BioMed Inc recently announce their entry into a final license agreement with The Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for Biotechnology (RGCB) for the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
COPD Market Set to Hit $14.1 Billion by 2025
The chronic obstructive pulmonary disease (COPD) space across the eight major markets of the US, France, Germany, Italy, Spain, the UK, Japan, and Australia, is set to rise from $9.9 billion in 2015 to around $14.1 billion by 2025, representing a compound annual growth rate of 3.7%, according to research and consulting firm GlobalData.
IntelGenx Receives Patent for Topical Oral Film Technology
IntelGenx Corp. recently announced that the United States Patent and Trademark Office has issued US Patent 9,668,970 covering the design and manufacturing of topical oral films (TOF) for the local (topical) treatment of diseases of the oral mucosa using mucoadhesive particles.
Lubrizol Invests $60 Million to Expand Particle Sciences, Vesta & Other Facilities
The Lubrizol Corporation recently announced its LifeSciences business continues to invest in its key capabilities through a variety of planned expansions. During this latest phase, a $60-million investment will focus on new product solutions, capacity expansion, and additional cGMP manufacturing.
FAQs on What Happens If You Miss the Serialization Deadline
Serialization affects all stages of the supply chain and with many companies, small and large, unprepared for the scope of regulations and data support required it leads to the question: what happens if you miss the serialization deadline?
Acasti Pharma & CordenPharma Announce Large-Scale Production of CaPre With Continuous Manufacturing
Acasti Pharma Inc. recently announced the achievement of a major corporate milestone by manufacturing the first cGMP batches of CaPre®, Acasti’s omega-3 pharmaceutical product candidate, produced with a proprietary and innovative continuous manufacturing process developed in partnership with CordenPharma.
Vetter & Microdermics Enter Into Strategic Agreement to Develop Innovative Microneedle Drug Delivery Systems
Vetter, a leading and innovative provider of aseptic prefilled drug delivery systems and Microdermics Inc., a Vancouver-based medical device company developing a novel hollow, metal microneedle drug and vaccine delivery system, recently announced that they have entered into a strategic cooperation agreement.
Pion Inc. Acquires Sirius Analytical Instruments Ltd.
Pion Inc., an industry leader in analytical instrumentation for drug development for the pharmaceutical industry, recently announced the acquisition of Sirius Analytical Instruments Ltd., headquartered in East Sussex, United Kingdom.
Hovione Announces Start of Phase 1 Clinical Trial
Hovione will soon initiate recruitment for its Phase 1 clinical trial of HY02, a proprietary minocycline sterile ointment to treat a subset of ocular surface inflammation, generally manifesting on the inner edge of the eyelids, leading to eye irritation and sometimes more severe symptoms such as blurring of the vision and/or irritation of the cornea.
PCT Now a Global CDMO as Part of Hitachi Chemical
PCT announced that Hitachi Chemical Co. America, Ltd. (Hitachi Chemical’s consolidated subsidiary) completed its purchase of the 80.1% remaining membership interest in PCT from Caladrius Biosciences.
First-in-Class Innovation a Key Strategy for Pharmaceutical Companies in a Harsh Market Environment
Fewer than two in 10 medicines exceed the average pharmaceutical R&D cost required to bring a drug to market when the risks of failure to reach market approval are factored in, according to business intelligence provider GBI Research.
Thermo Fisher Scientific to Acquire Patheon for $7.2 Billion
Thermo Fisher Scientific Inc., the world leader in serving science, and Patheon N.V., a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, today announced that their boards of directors have approved Thermo Fisher's acquisition of Patheon
Adamas Signs $100-Million Royalty-Backed Note Agreement
Adamas Pharmaceuticals, Inc. recenbtly announced that it has entered into a $100-million royalty-backed note agreement with HealthCare Royalty Partners (HCR).
Lupin Announces Opening of New Expansion at its NJ Manufacturing Site
The leadership of Lupin Limited gathered along with state and local leaders, including Rep. Bonnie Watson Coleman (DNJ – 12th District), to celebrate the grand opening of the company’s 100,000 square foot expansion of its manufacturing facilities in Somerset.
Aptar Pharma Partners With Kali Care to Develop Real-Time Medication Management Technology
Aptar Pharma and Kali Care have announced that they entered into a partnership in order to address the challenge of monitoring adherence in ophthalmic clinical trials.
Teneobio's Next Generation T Cell Redirection Antibody Platform for Cancer Biotherapeutics Offers Prospects of Reducing Cytokine Release
Teneobio, Inc, a next-generation antibody therapeutics company, recently announced the discovery of a large panel of human anti-CD3 binders with diverse affinities and tune-able T-cell activation.
Genisphere Begins Collaborative & Sponsored Research Program With the University of Maryland
Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia Muro.
Pharmatek Adds Further cGMP Spray Drying Capacity in Response to Demand for Improved Pharmaceutical Solubility
Catalent Pharma Solutions recently announced that it is increasing spray drying capacity at its Pharmatek, San Diego, CA, facility with the installation of an additional GEA Niro Mobile Minor unit.
Q BioMed Announces Licensing Agreement
Q BioMed Inc. and ASDERA LLC recently announced a licensing agreement that provides Q BioMed with the worldwide exclusive rights to ASDERA's ASD-002, which is being developed to treat a rare pediatric nonverbal disorder. Under the terms of the agreement, Q Biomed receives global rights to develop and commercialize the drug in the rare pediatric disease market.
 



Copyright © 2017  Drug Development & Delivery All Rights Reserved. Privacy Policy / Terms and Conditions